Clinical trial
Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
NCT00434798 · University of Vermont, Other · Unknown status
Key facts
| NCT number | NCT00434798 |
|---|---|
| Title | Campylobacter Jejuni Challenge Model Development: Dose Ranging Study |
| Official title | Campylobacter Jejuni Challenge Model Development: Dose Ranging Study |
| Lead sponsor | University of Vermont, Other |
| Collaborators | Naval Medical Research Center U.S. Fed TD Vaccines A/S Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Campylobacter Infections |
| Intervention type | Biological |
| Interventions | Campylobacter jejuni strains CG8421 and BH-01-0142 |
| Enrollment | 50 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Feb 13, 2007 |
| Last update posted | Jun 5, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: